Part 1 - Beyond the Beam 2.0: An Updated Radiation Oncology Curriculum for Radiopharmaceutical Therapy

Presenters introduce the curriculum, radiopharmaceutical therapies (RPTs) in general, radiobiology of RPTs, and chemistry of RPTs. This includes discussion of pharmacokinetics, biodistribution, dose rate, subcellular targeting, molecular and cellular effects of beta/alpha emitters, deterministic and stochastic effects, and toxicities.

Topics:

  • Introduction to RPT, Curriculum Overview and Radiobiology I ‒ Ana Kiess, MD, PhD
  • Chemistry of Radiopharmaceuticals ‒ Freddy E. Escorcia, MD, PhD
Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 2.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 2.00 Certificate of Attendance
    This activity was designated for 2.00 AMA PRA Category 1 Credit™.
Course opens: 
07/31/2026
Course expires: 
07/30/2028
Cost:
$0.00
Part of: 
Beyond the Beam 2.0: An Updated Radiation Oncology Curriculum for Radiopharmaceutical Therapy
Rating: 
0

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing education to physicians.

Available Credit

  • 2.00 AMA PRA Category 1 Credit™

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 2.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 2.00 Certificate of Attendance
    This activity was designated for 2.00 AMA PRA Category 1 Credit™.

Price

Cost:
$0.00
Please login or register to take this course.